| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |